Emerging trends in AYUSH: AYUSH sector has surged to USD 24 billion in 10 years

Published On 2024-03-25 04:00 GMT   |   Update On 2024-03-25 04:00 GMT

New Delhi: The 7th CII AYUSH Conclave, organized by the Confederation of Indian Industry, convened on Friday with a focus on "Emerging trends in AYUSH: Unleashing the market potential," spotlighting the monumental growth of the AYUSH sector over the past decade.Gathering esteemed opinion leaders from the AYUSH industry, along with academicians, practitioners, government stakeholders,...

Login or Register to read the full article

New Delhi: The 7th CII AYUSH Conclave, organized by the Confederation of Indian Industry, convened on Friday with a focus on "Emerging trends in AYUSH: Unleashing the market potential," spotlighting the monumental growth of the AYUSH sector over the past decade.

Gathering esteemed opinion leaders from the AYUSH industry, along with academicians, practitioners, government stakeholders, innovators, and healthcare professionals, the conclave delved into strategies for positioning AYUSH products in the global market, stimulating demand, and exploring future opportunities.

It also witnessed discussions on the role of AYUSH in achieving universal health coverage, the entrepreneurship ecosystem of the sector and the modern-day perspective on AYUSH.

Also Read:Yoga For Women Empowerment: Yoga Mahotsav begins 100 days countdown to IDY 2024

According to ANI, Padmashri Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH draw attention of the stakeholders towards how AYUSH sector has achieved a value of 24 billion in 10 years.

He underscored the escalating global acceptance and domestic demand for AYUSH products and services in the post-COVID era, emphasizing the Ministry's concerted efforts to bolster research and evidence-building initiatives.

Highlighting collaborative endeavours, Kotecha disclosed the establishment of Advanced Centers for Integrative Health Research in select AIIMS institutions nationwide, in conjunction with the Indian Council of Medical Research (ICMR). Furthermore, he outlined collaborative ventures with AIIMS to establish a Department of Integrative Medicine, aiming to bridge modern healthcare practices with traditional AYUSH therapies.

Moreover, Kotecha showcased the Ayush Grid platform's pivotal role in digitizing service delivery across six functional areas, including health services, education, research, drug administration, medicinal plants, and capacity building, alongside media outreach.

Next, he highlighted that for achieving quality benchmarks across products and services, more work is to be done, industry and government should join hands towards achieving this objective.

Dr Rabinarayan Acharya, Director General, Central Council for Research in Ayurvedic Sciences (CCRAS) highlighted the government efforts towards strengthening the sector, collaborative research efforts to generate evidence, reports ANI.

He mentioned that the Ministry will help develop three key botanicals while ensuring quality, safety, and efficacy by 2030.

Shashwat Goenka, Chairman of the CII National Taskforce on AYUSH and Director of PCBL Limited extolled the holistic well-being philosophy advocated by AYUSH, underlining its significance in contemporary healthcare paradigms.

Rajiv Vasudevan, Co-Chairman, CII National Taskforce on AYUSH and MD & CEO, Apollo Ayur VAID Hospitals apprised the audience that the terminology defining diseases in Ayurveda, Unand Siddha medicine has been indexed as a code and included in the WHO Disease Classification Series, Global Centre of Traditional Medicine (GCTM) has been launched in India, IRDAI mandate to cover AYUSH treatments under insurance cover are big steps towards mainstreaming AYUSH.

AYUSH Sector Booms to USD 24 Billion in a Decade, Embracing Global Recognition

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News